For horses that respond to OSPHOS and maintain their medical advancement for 6 months, it is best to re-administer only when clinical symptoms recur.  The drug’s labeling to verify the data stays truthful, full, and not misleading; and Dependant on this information and facts, FDA questioned the business to include additional adverse react